iShares Biotechnology ETF (NASDAQ:IBB) Shares Purchased by Waverly Advisors LLC

Waverly Advisors LLC boosted its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 80.6% during the 1st quarter, Holdings Channel reports. The institutional investor owned 11,220 shares of the financial services provider’s stock after acquiring an additional 5,006 shares during the period. Waverly Advisors LLC’s holdings in iShares Biotechnology ETF were worth $1,540,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. International Assets Investment Management LLC acquired a new stake in shares of iShares Biotechnology ETF in the fourth quarter valued at $76,425,000. Global Assets Advisory LLC acquired a new stake in shares of iShares Biotechnology ETF in the first quarter valued at $66,059,000. BNP Paribas Financial Markets boosted its holdings in iShares Biotechnology ETF by 25.7% in the first quarter. BNP Paribas Financial Markets now owns 2,055,373 shares of the financial services provider’s stock valued at $282,038,000 after purchasing an additional 420,053 shares during the period. Gray Foundation acquired a new position in iShares Biotechnology ETF during the 4th quarter worth $17,890,000. Finally, Miller Investment Management LP increased its holdings in iShares Biotechnology ETF by 2,394.4% during the 4th quarter. Miller Investment Management LP now owns 90,122 shares of the financial services provider’s stock worth $12,243,000 after purchasing an additional 86,509 shares during the period. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 0.0 %

Shares of IBB opened at $147.88 on Wednesday. The stock has a 50-day simple moving average of $139.17 and a 200-day simple moving average of $136.09. iShares Biotechnology ETF has a 1 year low of $111.83 and a 1 year high of $149.53.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.